This month, the Judicial Panel on Multidistrict Litigation released their latest report showing 7,606 Yaz lawsuits are still pending in a federal multidistrict court in the Southern District of Illinois.
The cases had numbered above 10,000 in recent years, until Bayer, who makes Yaz and Yasmin, began a massive settlement program for those suffering blood clot injuries.
Since 2012, the company has paid out over $1.8 billion to nearly 9,000 women and their families, for deep vein thrombosis and pulmonary embolisms caused by the drug.
The number of pending cases remains high though since lawyers are still assisting those who haven’t filed a claim yet.
Last week, Judge David Herndon, who oversees the federal Yaz cases, put pressure on Bayer to step up the settlements by scheduling many unresolved cases for trial next year.
However, lawyers urge anyone who hasn’t yet looked into a claim to do so, as time is running out.
Judicial Panel on Multidistrict Litigation. (September 15, 2014). Retrieved from http://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-September-15-2014.pdf
Elmiron is a mild blood-thinner drug that has been around since 1996 and is prescribed to treat bladder pain or inflammation, a condition called interstitial cystitis.
Since many of the companies that sold asbestos or used it in their products have long since gone out of business, people who are diagnosed with asbestos-related cancers often think it’s too late to file a lawsuit.